Company ProfilePremium

Jsmart Technologies Group Limited

Company Profile Analysis

Ticker: 0567.HK

ESOMAR 23 Corporate BadgeISO Certifications Badge
Jsmart Technologies Group Limited - Company showcase

Year Founded & Workforce

1990

204 Employees

Jsmart Technologies Group Limited logo

Jsmart Technologies Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Jsmart Technologies Group Limited Overview

Key identifiers

FieldDetailSource
Legal nameJsmart Technologies Group LimitedAR 2025-26
Chinese secondary name金安具身智能科技集團有限公司 (stock short name 金安智能)AR 2025-26
Former namesDaisho Microline Holdings Limited (大昌微綫集團有限公司)AR 2025-26; HKEX notice 23 Jun 2026
Founding / listingListed on the HKEX Main Board on 31 January 1990. Aggregators give 1990 as the incorporation year.irasia.com profile; Finnomena
Incorporation jurisdictionBermuda (exempted company with limited liability)AR 2025-26
Registered officeVictoria Place, 5th Floor, 31 Victoria Street, Hamilton HM 10, BermudaAR 2025-26
Head office / principal place of businessSuite 22C, 22/F, 228 Electric Road, North Point, Hong Kong (from 15 May 2026). Previously Unit A, 10/F, Fook Hing Industrial Building, 33 Lee Chung Street, Chai Wan.AR 2025-26; Morningstar
Exchange / tickerStock Exchange of Hong Kong, Main Board; 0567 (00567.HK)HKEX
ISINBMG2624V1063MarketsMojo; user list
CUSIPNot publicly disclosed (not applicable to a HKEX-only listing)—
Fiscal year end31 MarchAR 2025-26
Employees204 at 31 Mar 2026; 226 at 31 Mar 2025. For historical scale: 1,505 at 31 Mar 2007 and 2,001 at 31 Mar 2006.AR 2025-26; AR 2007
AuditorPrism Hong Kong Limited (Registered Public Interest Entity Auditor)AR 2025-26
Legal advisersMichael Li & Co. (Hong Kong law); Appleby (Bermuda law)AR 2025-26
Share registrarsPrincipal: Appleby Global Corporate Services (Bermuda) Ltd. Hong Kong branch: Tricor Investor Services Ltd.AR 2025-26
Shares in issue1,613,287,570 ordinary shares of HK$0.10 each. Authorised capital is HK$400 million (4 billion shares).AR 2025-26; August 2026 monthly return
Market capitalisationAbout HKD 419.5 million at HK$0.260 per share (16 July 2026 quote). Implied check: 1,613.29M shares × 0.26 = 419.5M. A live October 2026 price was not verifiable.Investing.com
Websitewww.jsmartech.hk (formerly www.irasia.com/listco/hk/daisho)AR 2025-26
Principal bankersBank of China; Bank of Communications; China Merchants Bank; Chiyu Banking; Nanyang Commercial Bank; OCBC Bank (HK); CMB Wing Lung BankAR 2025-26
MetricFY2024FY2025FY2026
Employees at year end (number)—226204
Total staff costs incl. directors (HKD M)—24.521.9

Jsmart Technologies Group is a Hong Kong-headquartered, Bermuda-incorporated micro-cap in the middle of an attempted reinvention.

Its operating base is two small legacy manufacturing businesses in Guangdong:

  • printing and packaging, made in Shenzhen;

  • printed circuit boards (PCBs), made in Huizhou.

Together they generated only HK$43.4 million of revenue in FY2026, down from HK$106.5 million in FY2022. The group has been loss-making in each of the last five years.

In April 2026 control of the largest stake changed hands. Jsmart Technologies Limited, founded in 2024 by former CITIC Capital and Value Partners private-equity executive Dr. Sun Jingan, bought the 17.36% block. The company was then renamed around an "embodied intelligence" (AI plus robotics) strategy.

The new vision so far rests on two things:

  • a 15.12% associate stake in a Beijing AI-health-management platform;

  • a newly formed robotics joint subsidiary targeting healthcare, rehabilitation and elderly care.

The equity is therefore best viewed as an early-stage, thinly capitalised transformation option, not as an established robotics operator.

Data discrepancy flag

Investing.com describes the company as "a subsidiary of Kingboard Holdings Limited". This is not supported by the FY2026 annual report. Its register of substantial shareholders lists:

  • Spring Global / Ng Man Chan / Li Mi Lai (26.41% aggregate at 31 March 2026);

  • Apact Consultancy (6.44%).

Kingboard is not listed, and no Kingboard holding of 5% or more appears. The aggregator statement should be treated as erroneous or stale. Investing.com's descriptor of the company as an intelligent-robotics R&D and manufacturing business also overstates current operations. The disclosed revenue is entirely from PCB and printing.


Company's own description (Annual Report 2025-2026, Report of the Directors)

The company's principal activity is investment holding. It operates through four reporting segments:

  1. PCB: manufacturing and trading of printed circuit boards.

  2. Printing Business: manufacturing and trading of printing and packaging products.

  3. Trading of petroleum and energy products and related business: dormant, with no revenue since 2019.

  4. Investments holding.

The Chairman's Statement adds a narrative "Smart Healthcare Business Segment". This covers the associate investment in Beijing Weihang Yining and the April 2026 AI-robotics joint subsidiary. As of FY2026, this "segment" generated no consolidated revenue. The associate is equity-accounted.

The Chairman frames the strategy as "strategic expansion into AI and robotics industries" to diversify revenue streams. He describes these as high-growth markets the group could not previously reach.

Independent characterisation

In economic substance, Jsmart today is three things:

  1. A sub-scale contract manufacturer of printed and packaging products. It is customer-concentrated: the top customer accounts for 31% of group sales and the top five for 73% (FY2026). It is exposed to export-oriented consumer demand that customers are diversifying away from China.

  2. A very small PCB maker. Revenue was about HK$15.7 million in FY2026. Its boards go into:

    • smart residential buildings;

    • commercial-building central control systems;

    • consumer electronics;

    • (by management's description) cloud computing. It has no disclosed scale or technology advantage. Peers produce boards on volumes several orders of magnitude larger.

  3. A listed shell-like platform with a small investment book. This includes:

    • the equity-accounted 15.12% stake in Beijing Weihang Yining, carried at HK$29.8 million, or 32.7% of total assets;

    • a 40% joint-venture interest in Noricap Fund G.P. Limited, which holds an indirect 0.86% interest in an SFC-licensed cryptocurrency automated-trading-platform operator;

    • a newly formed robotics subsidiary.

Business and revenue model

DimensionCharacterisationEvidence
Product vs service100% of FY2026 consolidated revenue is from manufactured products: 63.8% printing/packaging and 36.2% PCB (derived)AR 2025-26 MD&A
Subscription / licensingNone disclosedAR 2025-26
Revenue recognitionProduct sales under HKFRS 15, mainly at a point in timeFY2023/FY2024 results announcements
Value chain positionMid-stream converter. Buys paper, inks, copper-clad laminate and chemicals; sells to OEMs and brand owners.AR 2025-26 ESG climate table
Customer typesB2B: brand owners and packaging buyers; electronics OEMs (building automation, consumer electronics)AR 2025-26
End-marketsConsumer goods packaging; smart buildings; consumer electronics; cloud/data infrastructure (claimed); NEV and embodied-AI (aspirational)AR 2025-26 Chairman's Statement
Customer concentrationLargest customer 31%; top five 73%AR 2025-26
Supplier concentrationLargest supplier 14%; top five 35%AR 2025-26
Currency exposureRMB, HKD and USD. No hedging derivatives in FY2026.AR 2025-26

Planned new model (aspirational)

Management's stated intent is to:

  • commercialise AI and intelligent robots in medical treatment, rehabilitation and elderly care, through the joint subsidiary formed on 7 April 2026;

  • "advance the application of technologies in the embodied intelligence sector" from the PCB base.

No revenue model, pricing, product specification, capital budget or timeline for these initiatives has been disclosed. The annual report states the group has no concrete plans for material investments or capital assets acquisitions for the coming 12 months. This sits awkwardly with the rebranding narrative.

Strategy

Stated strategic themes (paraphrased from AR 2025-26 Chairman's Statement and MD&A)

  1. Strategic expansion into AI and robotics ("embodied intelligence"). The aim is to diversify revenue streams and access high-growth markets the group could not previously reach. The name change is presented as aligning the corporate brand with this direction.

  2. Prudent management of legacy businesses. This includes cost control, supplier management, inventory optimisation, product-mix improvement and customer-base expansion in printing.

  3. Leveraging PCB capability for new demand. Targets are digital innovation, new energy vehicles and the embodied-intelligence sector.

  4. Smart healthcare. AI health management (Weihang Yining) and robotics for medical treatment, rehabilitation and elderly care (the April 2026 JV).

  5. Investment diversification. The Noricap Fund vehicle provides fund and financial-technology exposure.

Initiatives in the last 24 months

DateInitiativeTypeDisclosed targets
28 Mar 2025RMB28.5M capital injection for 15.12% of Weihang YiningStrategic investment (AI health)—
30 Jun 2025Noricap JV partner changed from LBG to HKFA ClearingInvestment vehicle restructuring—
FY2026Noricap completed an HK$18.1M investment for an indirect 0.86% of a crypto trading-platform operatorFinancial investment—
7 Apr 2026Joint subsidiary with Weihang Yining and Beijing Jsmart Embodied Intelligent System for AI and robots in healthcare and elderly careNew business launchNone disclosed
20 Apr 2026Board reshaped: Dr. Sun appointed EDLeadership—
Apr–Jun 2026Name change, new website, HQ moveRebranding—
FY2026ESG targets: 3%/10%/15% intensity reductions vs 2025 baseline (energy, waste, GHG Scope 1+2, water) over short, medium and long termSustainabilitySee Section 20

Medium-term financial targets / guidance

None disclosed.

  • The company provides no revenue, margin or profitability guidance.

  • It states it has no concrete plans for material investments or capital asset acquisitions over the coming 12 months.

  • No investor day, earnings call or presentation has been identified.

Products & Services

The company discloses very little product-level detail. Each item below reflects the maximum verifiable granularity.

Printing & Packaging (Shenzhen)

ItemDescriptionTarget customerLaunch / versionPricingFlagship
Printed and packaging productsCustom printing and packaging made to client specification, with emphasis on "high-quality" outputBrand owners and consumer-product companies; customers concentrated (top five = 73% of group sales)Long-standing; launch year not disclosedOrder-based; not disclosed—
Process notesUses inks (hazardous waste: waste ink cans 0.09 t in FY2026) and drying processes; packaging-material consumption cut 31% vs FY2025————

Printed Circuit Boards (Huizhou)

ItemDescriptionTarget customerLaunch / versionPricingFlagship
PCBs for smart residential buildingsControl-board applications in smart-home and building systemsBuilding-automation OEMs———
PCBs for commercial-building central control systemsBoards for HVAC, BMS and central controlCommercial building-systems OEMs———
PCBs for consumer electronicsGeneral consumer-electronics boardsConsumer-electronics OEMs———
PCBs for automotive / cloud computingEarlier profiles cite automotive; AR 2025-26 cites cloud computingAuto and cloud-hardware OEMs———

Technical specifications: layer count, HDI capability, materials and certifications are not publicly disclosed. Management notes the technical and quality-control teams have "over two decades" of industry experience.

Investments & New Initiatives

ItemDescriptionStatus
Beijing Weihang Yining Health Management Group (15.12% associate)Operates an AI medical system with a health-management platform integrating high-end medical resourcesCompleted in FY2026; carrying value HK$29.8M; share of loss HK$0.7M
AI and intelligent-robotics joint subsidiary (formed 7 Apr 2026)Commercial application and development of AI and robots in medical treatment, rehabilitation and elderly careNewly formed. Name, ownership split, capital and products not disclosed.
Noricap Fund G.P. (40% JV)Special-purpose fund vehicle; holds an indirect 0.86% stake in an SFC-licensed crypto automated-trading-platform provider (cost about HK$18.1M)Completed
Petroleum and energy tradingDormant since 2019Management "actively seeking" resumption (irasia profile, 2023)

No robotics product has been named, specified, priced or launched by the listed group as of the research date.

Financial Narrative

Source: AR 2025-26 five-year summary unless noted. Currency HKD. Fiscal years end 31 March.

Income statement

Notes on the income statement

  • Gross profit for FY2024 and FY2025 is from the profit warning (about HK$17.7M and HK$10.2M). FY2026 is from the results announcement.

  • Administrative expenses come from the FY2023 results announcement.

  • Loss before tax is identical (HK$21.285M) in FY2025 and FY2026 per the five-year summary; the difference is in tax.

Per-share data (HK cents)

Notes: FY2023, FY2024 and FY2026 EPS are as reported (Moomoo/PUBT). FY2022 and FY2025 are derived from the net loss divided by 1,613,287,570 shares. Diluted equals basic because no options are outstanding. No dividends were declared in any year shown.

Margins (%, derived)

Notes: Gross margin for FY2025 and FY2026 is as reported (19.3% and 21.9%). FY2022 margins use continuing revenue. Operating and EBITDA margins are not computable.

Revenue CAGR, FY2022–FY2026 (continuing): (43,426 / 106,471)^(1/4) − 1 = −20.1% per year.

Balance sheet

Notes on the balance sheet

  • Total assets and total liabilities are derived as sums.

  • Cash: FY2026 is HK$3.23M per PUBT; borrowings are about HK$3.2M (2025: nil). Net debt for FY2026 is approximately zero.

  • The short-term vs long-term split of debt is not publicly disclosed in retrieved extracts. The rise in non-current liabilities suggests part may be long-term or lease-related.

  • Goodwill and intangibles are not disclosed and are presumed immaterial.

Cash flow

AR 2025-26 states that no securities were repurchased in FY2026, and there were no capital commitments at year end.

Commentary on trends, inflections and drivers

1. Structural revenue decline.

  • Continuing revenue fell from HK$106.5M (FY2022) to HK$43.4M (FY2026), a −20.1% CAGR.

  • The only up-year was FY2024 (+2.2%), driven by an 11.5% printing rebound.

  • The FY2025 collapse (−38.0%) was led by a HK$25.2M fall in printing revenue. The profit warning attributes this to customers turning cautious amid global trade tensions. Management repeatedly says customers are "sourcing from different countries to diversify risk", which is a classic China+1 headwind for a Shenzhen converter.

2. Gross margin is resilient but too small to matter.

  • Gross margin held around 19–22% and improved to 21.9% in FY2026 on lower staff costs.

  • But absolute gross profit (HK$9.5M) is far below the cost base. Staff costs alone were HK$21.9M, and administrative expenses historically ran at HK$27–31M.

  • The business is therefore structurally loss-making at current scale.

3. Persistent losses erode equity.

  • Cumulative net losses over FY2022–FY2026 total about HK$109.4M.

  • Equity fell 62% from HK$132.7M to HK$49.8M. Equity per share is about HK$0.031.

4. FY2026 liquidity inflection.

  • Cash fell from HK$19.9M to HK$3.2M (−HK$16.7M), mainly because the RMB28.5M (about HK$30.5M) Weihang Yining capital injection completed during the year.

  • The group took on HK$3.2M of borrowings, and the current ratio dropped from 1.80x to 1.19x.

  • Net current assets of HK$7.3M equal roughly four months of the FY2026 net-loss run-rate. This makes near-term capital raising highly probable absent a turnaround or asset monetisation. This is analyst inference, not company guidance.

5. Balance-sheet composition shift.

  • One illiquid, equity-accounted minority stake (HK$29.8M) now represents 32.7% of total assets.

  • Recoverability of this stake is a key audit and valuation judgment. No impairment was recognised in FY2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsOperating baseStatus

Manufacturing and trading of printing and packaging products ("Printing Business")

Printed products and packaging made to customer specification

Shenzhen factories, over 125,000 sq ft

Active; largest revenue contributor

Manufacturing and trading of PCB

Printed circuit boards for smart buildings, central control systems, consumer electronics, cloud computing and automotive

Huizhou factories

Active

Trading of petroleum and energy products and related business

Commodity and energy trading

—

Suspended since 2019; no revenue

Investments holding

Noricap Fund JV (40%); other investments

Hong Kong

No revenue

"Smart Healthcare" (narrative only)

15.12% associate in Weihang Yining; April 2026 AI-robotics joint subsidiary

Beijing

Not a separately reported revenue segment in FY2026

Revenue by Segment

SegmentFY2022FY2023FY2024FY2025FY2026

Printing and packaging revenue (HKD K)

70,81752,95759,03633,79027,700

PCB revenue derived (HKD K)

35,65430,80126,54819,30715,726

Petroleum and energy trading revenue (HKD K)

00000

Total continuing revenue (HKD K)

106,47183,75885,58453,09743,426

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%) and Revenue by Segment (%)

MetricFY2023FY2024FY2025FY2026

Printing revenue YoY growth (%)

-25.211.5-42.8-18.0

PCB revenue YoY growth derived (%)

-13.6-13.8-27.3-18.5

Printing share of total revenue (%)

63.269.063.663.8

PCB share of total revenue (%)

36.831.036.436.2

Results by Segment

Segment resultFY2025FY2026

Printing Business segment result (HKD Mn)

-11.0-12.6

PCB segment result (HKD Mn)

-1.2-1.6

Petroleum trading segment result (HKD Mn)

00

Segment Margins & Growth (%)

MetricFY2025FY2026

Printing segment margin derived (%)

-32.6-45.5

PCB segment margin derived (%)

-6.2-10.2

Income Statement

MetricFY2022FY2023FY2024FY2025FY2026

Revenue continuing (HKD K)

106,47183,75885,58453,09743,426

Revenue incl discontinued (HKD K)

109,23883,75885,58453,09743,426

Gross profit (HKD K)

——17,70010,2009,530

Loss before tax (HKD K)

-29,149-25,868-11,873-21,285-21,285

Income tax credit or expense (HKD K)

21-149015914

Net loss attributable to owners (HKD K)

-29,128-26,017-11,873-21,126-21,271

Administrative expenses (HKD K)

-31,157-26,754———

Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Basic EPS (HK cents)

-1.81-1.61-0.74-1.31-1.32

Diluted EPS (HK cents)

-1.81-1.61-0.74-1.31-1.32

Dividend per share (HK cents)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

——20.719.321.9

Pre-tax margin (%)

-27.4-30.9-13.9-40.1-49.0

Net margin (%)

-27.4-31.1-13.9-39.8-49.0

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Non-current assets (HKD K)

50,54349,93046,89648,40944,991

Current assets (HKD K)

125,06594,67378,21356,50546,107

Total assets (HKD K)

175,608144,603125,109104,91491,098

Current liabilities (HKD K)

42,80138,37631,28231,39538,792

Non-current liabilities (HKD K)

146313141,0002,529

Total liabilities (HKD K)

42,94738,68931,29632,39541,321

Total equity (HKD K)

132,661105,91493,81372,51949,777

Net current assets working capital (HKD K)

82,26456,29746,93125,1107,315

Cash and bank balances (HKD K)

———19,9003,200

Interest-bearing borrowings (HKD K)

———03,200

Net debt (HKD K)

———-19,9000

Investment in associate Weihang Yining (HKD K)

————29,800

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Dividends paid (HKD K)

00000

Share buybacks (HKD K)

00000

Net change in cash and bank balances (HKD K)

————-16,700

Margin Analysis (%) and Financial Ratios (x)

RatioFY2023FY2024FY2025FY2026

ROE on average equity (%)

-21.8-11.9-25.4-34.8

ROA on average assets (%)

-16.3-8.8-18.4-21.7

Current ratio (x)

2.472.501.801.19

Debt to equity excl leases (%)

——0.06.4

Gearing per company (%)

——2.88.6

Asset turnover (x)

0.520.630.460.44

Capital Markets

ItemValueSource / date

Last verified price

HK$0.260

Investing.com, 16 Jul 2026 (previous close HK$0.295)

Earlier reference price

HK$0.089 (market cap about HK$143.6M)

Simply Wall St screen; date not specified, pre-2026

Other reference

HK$0.29, shown with +192% change (period ambiguous)

MarketsMojo

3-year trend

Share price up about 23% per year over three years while EPS fell about 9% per year

Simply Wall St

1-year and 5-year returns

Not verifiable precisely

—

Market cap

About HK$419.5M at HK$0.26

Derived

Trailing EPS

−HK$0.013

Investing.com; Simply Wall St

Valuation Snapshot

MultipleValueCalculation

P/E

Not meaningful (loss-making)

—

P/B

About 8.4x

HK$419.5M ÷ HK$49.8M equity

EV/Sales

About 9.7x

EV ≈ market cap + debt − cash ≈ HK$419.5M; ÷ FY2026 revenue HK$43.4M

EV/EBITDA

Not meaningful

EBITDA undisclosed and likely negative

Capital Markets — Analyst consensus

ItemStatus

Analyst consensus

No sell-side coverage identified

Dividend history and policy

No dividends FY2022–FY2026. No distributable reserves under the Bermuda Companies Act at 31 Mar 2025 or 31 Mar 2026.

Buybacks

None in FY2026; no treasury shares; no authorisation beyond the general mandate disclosed

Credit ratings (Moody's / S&P / Fitch)

None; unrated

Debt maturity profile

About HK$3.2M of interest-bearing borrowings; maturity split not disclosed

Share capital

1,613,287,570 shares; authorised 4bn at HK$0.10 par. Unchanged through Aug 2026.

Option overhang

0 options outstanding; mandate capacity 161,328,757; scheme expiring around Nov 2026

Share Count (millions) and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Shares in issue (millions)

1,613.291,613.291,613.291,613.291,613.29

Book value per share (HK cents)

8.226.575.824.503.09

Analyst Conclusions

Management guidance

No quantitative guidance is given. Qualitatively:

  • the printing segment is expected to remain under sales pressure;

  • PCB demand remains pressured, with hoped-for relief from digital innovation and NEV demand;

  • the group will "undergo strategic expansion into AI and robotics" while running legacy businesses prudently.

Consensus expectations

No analyst consensus exists.

Bull case

  1. Platform re-rating with asset injection. The new 17.36% holder controls an embodied-AI venture that shares the group's new name. Injecting real robotics revenue into a listed vehicle with a clean float could transform the investment case, and the market already prices this at about 8x book.

  2. Healthcare-robotics channel. The JV pairs Weihang Yining's health-management network (15.12% associate, HK$29.8M carrying value) with robotics capability. It targets China's ageing-population demand within a smart-robots market growing about 21% a year (TBRC).

  3. Low leverage, small cost base. Gearing is 8.6% and headcount fell to 204. That leaves room to raise equity or debt and pivot without legacy obligations. Historical litigation is resolved.

Bear case

  1. Funding cliff. Cash is HK$3.2M and net current assets HK$7.3M against an annual loss of about HK$21M. A dilutive raise or asset sale appears unavoidable within roughly 12 months.

  2. Narrative ahead of substance. There is no disclosed robotics product, R&D spend, IP or revenue. Management itself says it has no concrete material-investment plan for the next 12 months.

  3. Legacy erosion is structural. Revenue has fallen at a −20% CAGR since FY2022. Printing customers are relocating sourcing, and 73% of sales come from five customers, so further losses could be abrupt.

Catalysts and monitorables (next 12 months)

Interim results: for the six months to 30 Sep 2026, expected around November 2026. Watch cash, borrowings, the first consolidation of the robotics JV, and any going-concern language.

  • Any placing, rights issue or convertible issuance, including size, price and subscriber identity.

  • Announcements of asset injection or acquisition from Jsmart-related entities, and HKEX RTO treatment.

Disclosure of the robotics JV: shareholding, capital, first products or contracts.

Weihang Yining: performance and impairment testing.

Noricap/crypto stake: valuation or exit.

2026 AGM poll results: and any further board changes (e.g., a CEO appointment).

  • Expiry or renewal of the share option scheme around November 2026, which could be used to incentivise a robotics team.

Customer losses: in printing; PCB order trends.

Analyst verdict

Jsmart Technologies Group is, at present, a rebranding without yet being a robotics company.

The listed entity's operating reality is two sub-scale Guangdong manufacturing businesses. Their combined revenue has fallen from HK$106.5 million to HK$43.4 million in four years, and they lose about HK$21 million a year. The FY2026 balance sheet shows the strain clearly:

  • cash fell to HK$3.2 million;

  • the current ratio fell to 1.19x;

  • one-third of total assets is now tied up in an equity-accounted, illiquid minority stake in a Beijing health-management platform.

Nothing in the filings shows proprietary robotics technology, R&D spending, patents or customer contracts at the listed-group level.

The strategic logic of the April 2026 change of the substantial shareholder is nevertheless clear. Dr. Sun Jingan brings serious capital-markets pedigree from CITIC Capital and Value Partners PE, and he controls an embodied-AI venture named for the new listed vehicle. A clean Main Board platform with 25% public float, minimal debt and resolved legacy litigation is an efficient vehicle to house and finance robotics assets. The joint subsidiary with Weihang Yining in healthcare, rehabilitation and elderly-care robotics points to the intended direction.

The equity's valuation, roughly 8x book and nearly 10x sales at HK$0.26, already discounts a meaningful part of that optionality. The near-term path almost certainly runs through dilution: either a cash raise or an asset injection paid in shares. Minority holders' outcomes will depend on the pricing and independence of those transactions, and on HKEX treatment of any reverse-takeover-like restructuring.

Verdict: a speculative special situation, not an investable operating story. Monitor the November 2026 interim results, any capital-raising terms, and connected-transaction disclosures as the decisive evidence. Absent concrete asset injection, the fundamentals point to continued equity erosion.


APPENDIX: SOURCE LIST

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedAgeBackgroundEducation

Lee Man Kwong

Chairman; Executive Director; Chair of Nomination Committee; Remuneration Committee member

INED 14 Dec 2016 → NED 1 Mar 2017 → ED 1 Jun 2018 → Chairman 16 Oct 2020

71

Senior partner, Chan, Lau & Wai, Solicitors. Former directorships at CCT Fortis, Neo Telemedia (chairman), Sau San Tong, Mei Ah Entertainment, Uni-Bio Science, Asia Standard Hotel.

Solicitor (Hong Kong 1983; England & Wales; Singapore)

Dr. Sun Jingan

Executive Director; Authorised Representative

20 Apr 2026

52

Founder and director of Jsmart Technologies Limited (2024); robotics and embodied-AI commercialisation. Formerly director and GM of CITIC Capital (Qingdao) Investment Mgmt; director and GM of Value Partners Private Equity Fund; investment director at China Shipping Fund; VP at CITIC Capital Holdings; manager at China CITIC Bank and CITIC Bank International (1999–2021).

BA Investment Economics, Shandong Univ. of Finance & Economics (1996); MA and PhD Finance, Renmin University (1999, 2006); CFA

Yau Pak Yue

Non-executive Director; Audit Committee member

3 Sep 2020

57

Former Big Four partner (2005–2012); former Chief Knowledge Officer of Guangzhou Chengfa Capital; director of Ewin Advisory. Multiple HK-listed INED roles (442, 309, 1636).

B.Com (Accountancy), University of Wollongong; HKICPA; FCPA (Aus)

Dr. Chan Yau Ching, Bob

INED; member of all three committees

3 Sep 2018

63

MD of KBR Capital and KBR Fund Management; INED of Lee's Pharmaceutical (950) since 2002; former ED of Celestial Asia Securities; former CEO of Moli Group

BBA CUHK (1984); MBA Wisconsin-Madison (1986); PhD Finance, Purdue (1994)

Dr. Leung Hoi Ming

INED; member of all three committees

30 Apr 2021

58

Former SVP, Treasury & Markets, DBS Bank; Citibank quant analyst (1996); INED of Yuan Heng Gas (332)

BSc CUHK (1990); MSc and PhD Mathematics, Caltech (1993, 1996); MSc Investment Mgmt, HKUST (1999)

Lin Ying

INED; Chair of Audit and Remuneration Committees; Nomination Committee member

20 Sep 2024

50

Director of Shandong Rio Culture & Technology; former Deloitte FAS, PwC, Arthur Andersen; INED of 442 and 332

BEcon (Taxation), Guangdong Univ. of Finance & Economics (1998); CICPA

Wong Siu Hung, Patrick

Former NED (previously ED)

Resigned 20 Apr 2026

———

Executive Leadership Team

NameRoleAgeJoinedBackground

Ou Zhong

CEO of a major PRC subsidiary

50

Jun 2017

23+ years in electronics operations, R&D and market development; ex-state-owned enterprises; BEng Automation, Guangdong University of Technology

Ye Xian Bang

Production Manager of a major PRC subsidiary

55

Sep 2013

13+ years in printing and packaging; Huizhou University graduate

Ng Yu Ho

Company Secretary (per AR 2025-26)

——

The August 2026 monthly return was signed by 陳駿軒 as company secretary, implying a change after July 2026.

Governance Overview

AttributeStatus

Board size

6 (2 ED, 1 NED, 3 INED)

Independence

50% INEDs, which meets the HKEX one-third minimum

Chair/CEO separation

No group CEO is named. The Chairman is an executive director, so the roles are effectively combined at board level.

Committees

Audit (chaired by an INED; 3 INEDs plus 1 NED); Remuneration (chaired by an INED); Nomination (chaired by the Chairman)

Gender diversity

1 of 6 directors female (Ms. Lin Ying)

Director share ownership

Lee Man Kwong holds 10,000 shares (0.0006%). Dr. Sun is deemed interested in 280,000,000 shares (17.36%) via Jsmart Technologies Limited, which is co-owned with his spouse Ms. Ma Ying (post-April 2026).

Overboarding flags

Several directors hold multiple HK-listed directorships (e.g., Yau: 3 current INED roles plus a history of 10+ boards)

Major Shareholders

HolderShares%Note

Spring Global Enterprises Ltd (100% Ng Man Chan)

280,000,00017.36

Sold to Jsmart Technologies Ltd on 7 Apr 2026

Ng Man Chan (direct, via Spring Global, and jointly)

426,028,00026.41

120,068,000 direct + 280,000,000 Spring Global + 25,960,000 joint with spouse

Li Mi Lai (spouse)

426,028,000 (deemed)

26.41

Same interest

Apact Consultancy (Hong Kong) Co. Ltd (investment manager)

103,826,0006.44—

Major Shareholders — Jsmart Technologies Limited

HolderShares%

Jsmart Technologies Limited (Dr. Sun Jingan and Ms. Ma Ying)

280,000,00017.36

Ng Man Chan (direct)

120,068,0007.44

Ng Man Chan and Li Mi Lai (joint)

25,960,0001.61

Apact Consultancy (Hong Kong)

103,826,0006.44

Public float

≥25% confirmed

—

Competitive Landscape

Competitors by Segment

SegmentCompetitorListingRelative positioning vs Jsmart

PCB

Kingboard Holdings

HKEX: 0148

Vertically integrated laminate-to-PCB giant; orders of magnitude larger

PCB

Kingboard Laminates

HKEX: 1888

Upstream laminate supplier/competitor; vastly larger

PCB

Shennan Circuits

SZSE: 002916

High-end communications/server PCB leader

PCB

Victory Giant Technology

SZSE: 300476

AI-server and high-layer-count boards; much larger

PCB

Meiko Electronics

TSE: 6787

Japanese automotive and data-centre board maker

PCB

Elec & Eltek

SGX

HK-rooted PCB maker; larger scale

Printing & packaging

Hung Hing Printing Group

HKEX: 0450

Established HK printing and packaging group; larger

Printing & packaging

Numerous unlisted Pearl River Delta converters

—

Fragmented price competition

AI robotics (aspirational)

UBTech Robotics

HKEX: 9880

Listed humanoid/service-robot leader

AI robotics (aspirational)

Dobot

HKEX: 2432

Collaborative-robot specialist

AI robotics (aspirational)

Doosan Robotics

KRX

Cobot maker developing an agentic robot OS with Nvidia (Korea Herald, 2026)

Healthcare/elderly-care robotics

Fourier Intelligence and other rehab-robot specialists

Unlisted

Domain-specific incumbents

Competitor Detail

MetricJsmart FY2026

Revenue

HK$43.4M

Revenue growth

−18.3%

Gross margin

21.9%

Net margin

−49.0%

Company Snapshot

204

Employees

1990

Founded

Hamilton HM, Bermuda

Headquarters

SWOT Analysis

Strengths

  • Gross-margin resilience: 21.9% in FY2026, up from 19.3%, despite an 18.3% revenue decline, reflecting staff-cost reductions (AR 2025-26).
  • Low financial leverage: borrowings of only about HK$3.2M; gearing of 8.6%; no pledged assets, contingent liabilities or capital commitments at 31 Mar 2026 (AR 2025-26).
  • Strategic shareholder with relevant networks: Dr. Sun brings 20+ years at CITIC Capital, Value Partners PE and CITIC Bank, plus a robotics venture founded in 2024 (AR 2025-26).
  • Clean legacy: historical energy-trading litigation was extinguished by the FY2025 subsidiary disposals, per legal advisers (AR 2025-26).
  • Experienced operating managers: Ou Zhong (23+ years in electronics; with the group since 2017) and Ye Xian Bang (13+ years in printing; since 2013) (AR 2025-26).
  • Listed-platform value: Main Board listing since 1990; 25% public float maintained; 161.3M option capacity available (AR 2025-26; Aug 2026 monthly return).

Weaknesses

  • Chronic losses: net losses in each of FY2022–FY2026, totalling about HK$109.4M (five-year summary).
  • Revenue collapse: −20.1% CAGR from FY2022 to FY2026; revenue of HK$43.4M in FY2026 (five-year summary).
  • Liquidity squeeze: cash fell from HK$19.9M to HK$3.2M; current ratio fell from 1.80x to 1.19x; net current assets only HK$7.3M (AR 2025-26).
  • Customer concentration: largest customer 31%; top five 73% of sales (AR 2025-26).
  • Printing segment deeply loss-making: segment loss of HK$12.6M on HK$27.7M of revenue (AR 2025-26).
  • No disclosed R&D, patents or robotics product despite the AI rebrand (AR 2025-26; no disclosure found).
  • Asset concentration in an illiquid minority stake: Weihang Yining carried at HK$29.8M, or 32.7% of total assets (AR 2025-26).

Opportunities

  • Asset injection: potential injection of robotics assets from the Jsmart-affiliated ecosystem into the listed vehicle (inference; Section 11).
  • China elderly-care and rehabilitation robotics: the new JV directly targets this, and the smart-robots market is growing about 21% a year per TBRC (AR 2025-26; GII).
  • PCB pivot: repositioning toward NEV and embodied-AI hardware boards, as management has stated (AR 2025-26).
  • Monetising non-core holdings: the Noricap/crypto stake (HK$18.1M cost) and the dormant petroleum licence (AR 2025-26).
  • Capital raising at higher valuations: the robotics theme supports equity raising. Market cap was about HK$419M at HK$0.26 (Investing.com), against book equity of HK$49.8M.
  • Cost rationalisation: headcount already fell from 226 to 204, and staff costs fell HK$2.6M (AR 2025-26).

Threats

  • Structural export-sourcing shift: customers are diversifying away from China, per management's FY2026 printing outlook (AR 2025-26).
  • Going-concern pressure: at the FY2026 loss run-rate of about HK$21M a year against HK$3.2M cash and HK$7.3M net current assets (derived), funding is a real constraint.
  • Dilution risk: any equity raise to fund robotics would heavily dilute existing holders at current scale (inference).
  • Regulatory scrutiny: HKEX scrutiny of shell-like pivots, name changes and possible reverse takeovers (Listing Rules Chapter 14 context).
  • Intense robotics competition: listed leaders such as UBTech, Dobot and Doosan Robotics are already tying up with Nvidia (Korea Herald 2026).
  • Macro shocks: the Middle East conflict and oil spike from February 2026, plus trade barriers, are cited as disrupting recovery (AR 2025-26 Chairman's Statement).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
30 May 2025Supplemental announcement on the Weihang Yining subscriptionClarified terms of the largest investment
19 Jun 2025Profit warning: FY2025 loss about HK$21.3M (vs HK$11.9M); printing revenue −HK$25.2M; PP&E impairment about HK$4.0M; disposal loss about HK$3.1MConfirmed deterioration
24 Jun 2025FY2025 annual resultsRevenue HK$53.1M (−38%); net loss HK$21.1M
30 Jun 2025Noricap JV with LBG terminated; new JV with HKFA ClearingPartner default handled
Jul 2025Annual Report 2024-2025 published—
23 Sep 20252025 AGMRoutine
20 Nov 2025Interim results for the six months to 30 Sep 2025–
8 Dec 2025Notification letters to shareholders (interim report dissemination)Routine
Jan–Mar 2026Monthly returns: no change in share capitalRoutine
16 Jan 2026INED Dr. Chan resigned from China High Speed Transmission's boardDirector-information change
30 Mar 2026Announcement that substantial shareholder Spring Global was negotiating a sale of 17.36%Signalled change of control of the largest block
31 Mar 2026Clarification announcement on the possible share sale—
2 Apr 2026SPA signed: Spring Global → Jsmart Technologies Ltd (280M shares)New strategic shareholder
7 Apr 2026Transfer completed; AI-robotics healthcare joint subsidiary establishedStrategic pivot begins
20 Apr 2026Dr. Sun Jingan appointed ED; Wong Siu Hung, Patrick resignedBoard realigned with the new shareholder
24 Apr 2026Proposed name change announcedRebranding
6 May 2026SGM notice issued; board cites expansion into AI and robotics—
15 May 2026Head office moved to North PointOperational
22 May 2026SGM passed the name change 100%Shareholder endorsement
28 May / 1 Jun 2026Bermuda name-change certificates (effective 28 May)Legal effectiveness
9 Jun 2026Board-meeting date notice for FY2026 resultsRoutine
12 Jun 2026Hong Kong registration of the new name—
18 Jun 2026FY2026 results: revenue HK$43.4M (−18.3%); net loss HK$21.3M; cash HK$3.2M; gearing 8.6%Liquidity tightening
18 Jun 2026NED Yau Pak Yue resigned from Huscoke's board; joined China Metal Resources Utilization on 26 JunDirector-information change
25 Jun 2026Stock short name became "JSMART TECH" / "金安智能"; new websiteMarket-facing rebrand
16 Jul 2026Share price HK$0.260 (−11.9% on the day from HK$0.295); market cap about HK$419MVolatility after the rebrand
23 Jul 2026Annual Report 2025-2026 and AGM notice publishedFull disclosure
2 Sep 2026August monthly return: 1,613.29M shares; no options; public float ≥25%Signed by a new company secretary
25 Sep 20262026 AGM (re-elections; Prism re-appointment)–

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment: Total continuing revenue fell from HKD 106.5 Mn in FY2022 to HKD 43.4 Mn in FY2026.
Jsmart Technologies Group Limited — Revenue by Segment
Series (HKD Mn)FY2022FY2023FY2024FY2025FY2026
Total continuing revenue106.583.885.653.143.4
Printing and packaging revenue70.8535933.827.7
PCB revenue35.730.826.519.315.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.